New Drug Approvals
New Molecular Entity and New Therapeutic Biological Product Approvals Drug Name Active Ingredient Date FDA-approved use on approval date Daklinza daclatasvir 7/24/2015 To treat chronic hepatitis C virus (HCV) genotype 3 infections Odomzo sonidegib 7/24/2015 To treat patients with locally advanced basal cell carcinoma that has recurred following surgery or radiation therapy, or who are not candidates for surgery or radiation […]